低酸素症はクロマチンアクセシビリティと遺伝子発現の変化を通じてTh17/Tregバランスを調節する
Mariana Cázares-Olivera1, Shiyang Song2,3,4, Sofia Ylinen1
1Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Finland.
The FEBS journal
|December 24, 2025
まとめ
低酸素症はTヘルパー細胞のクロマチンアクセシビリティを変化させ、制御性T細胞(Treg)からTヘルパー17(Th17)細胞へのシフトを促進する。この発見は、炎症性疾患の発症に影響を与える新たなメカニズムを明らかにする。
科学分野:
- 免疫学
- 分子生物学
- 細胞生物学
背景:
- 低酸素症は炎症において重要であり、Tヘルパー17(Th17)細胞と制御性T細胞(Treg)のバランスに影響を与え、炎症性疾患に寄与する。
- 転写因子低酸素誘導因子1α(HIF-1α)はTh17細胞分化を促進するが、Th17細胞とTreg細胞のクロマチンアクセシビリティに対する低酸素症の影響は不明なままである。
研究 の 目的:
- 低酸素症がTh17細胞およびTreg細胞のクロマチンアクセシビリティをどのように変化させるかを調査する。
- これらの変化と、Th17/Tregバランスに影響を与える転写産物学的変化を相関させる。
主な方法:
- クロマチンアクセシビリティを評価するためのトランスポゾンアクセス可能クロマチンシーケンシング(ATAC-seq)アッセイ。
- 遺伝子発現プロファイルを分析するためのRNAシーケンシング(RNA-seq)。
- ATAC-seqおよびRNA-seqデータの統合解析。
主要な成果:
- 低酸素症は、Treg細胞においてTh17細胞よりも有意に遺伝子発現を変化させ、Hif1aの発現が増加した。
- Treg細胞における転写因子および転写因子3(STAT3)のmRNAおよびタンパク質の増加は、新たな低酸素症-STAT3調節メカニズムを示唆している。
- 転写因子(ETS1、IRF1、RUNX2、ATF3)を低酸素症におけるTヘルパー細胞分化の潜在的調節因子として同定した。
- 低酸素症は主要な遺伝子座におけるクロマチンアクセシビリティを増加させ、Th17細胞分化を促進し、Th17/Tregバランスをシフトさせた。
結論:
- 低酸素症は、クロマチンアクセシビリティおよび転写因子遺伝子発現の変化を通じてTh17/Tregバランスを調節する。
- 本研究は、低酸素症がTreg細胞分化にどのように影響し、炎症性状態に寄与するかについての洞察を提供する。
関連する概念動画
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
General Transcription Factors
6.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.6K


